Your shopping cart is currently empty

SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $3,720 | 3-6 months | 3-6 months | |
| 50 mg | $4,680 | 3-6 months | 3-6 months | |
| 100 mg | $6,200 | 3-6 months | 3-6 months |
| Description | SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes. |
| Targets&IC50 | SGLT1/ SGLT2 (human):29nM/20 nM |
| Molecular Weight | 669.85 |
| Formula | C37H55N3O8 |
| Cas No. | 1240305-17-2 |
| Smiles | O(C)C1=C(C=C(CC2=CC=C(/C=C/C(C(NC(C(NCCN(C)C)=O)(C)C)=O)(C)C)C=C2)C(C(C)C)=C1)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O |
| Relative Density. | 1.182 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.